A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
D000374:Aggression / Q000187:drug effects; D000661:Amphetamine / Q000494:pharmacology; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D002375:Catalepsy; D003909:Dexetimide / Q000494:pharmacology; D003916:Dextromoramide / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000378:metabolism*; D004338:Drug Combinations; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008614:Meperidine / Q000494:pharmacology; D008691:Methadone / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D010638:Phenoperidine / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D013239:Stereotyped Behavior / Q000187:drug effects; D013375:Substance Withdrawal Syndrome; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014839:Vomiting
D000701:Analgesics, Opioid; D004338:Drug Combinations; D011955:Receptors, Drug; D014149:Tranquilizing Agents; D010868:Pimozide; D003909:Dexetimide; D009020:Morphine; D008614:Meperidine; D003916:Dextromoramide; D000661:Amphetamine; D010638:Phenoperidine; D006220:Haloperidol; D001058:Apomorphine; D008691:Methadone; D004298:Dopamine